Skip to main content
Meagan Deming, MD, Infectious Disease, Baltimore, MD

MeaganDemingMDPhD

Infectious Disease • Baltimore, MD

Transplant/Immunocompromised States

Instructor

Join to view full profile

Dr. Deming is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Deming's full profile

Already have an account?

  • Office

    685 W Baltimore St
    Baltimore, MD 21201
    Phone+1 410-706-8333

Summary

  • Dr. Meagan Deming, based in Baltimore, MD, specializes in Infectious Disease with a subspecialty focus on Transplant/Immunocompromised States. Following her medical degree from the University of North Carolina at Chapel Hill School of Medicine, she completed a residency in Internal Medicine and a fellowship in Infectious Disease at the University of Maryland. Dr. Deming has substantial experience in transplant infectious disease. Her published work, notably in the areas of SARS-CoV-2 and COVID-19, has been cited extensively by her peers, indicating her significant contribution to this field of research.

Education & Training

  • University of Maryland
    University of MarylandFellowship, Infectious Disease, 2017 - 2022
  • University of Maryland
    University of MarylandResidency, Internal Medicine, 2015 - 2018
  • University of North Carolina at Chapel Hill School of Medicine
    University of North Carolina at Chapel Hill School of MedicineClass of 2015

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2019 - 2026
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Infectious Disease

Publications & Presentations

PubMed

Journal Articles

  • Accelerating Development of SARS-CoV-2 Vaccines — the Role for Controlled Human Infection Models  
    Meagan E Deming, Kathleen M Neuzil, The New England Journal of Medicine

Authored Content

  • Accelerating Development of SARS-CoV-2 Vaccines — the Role for Controlled Human Infection ModelsJuly 2020
  • Accelerating Development of SARS-CoV-2 Vaccines — the Role for Controlled Human Infection ModelsJuly 2020
  • Accelerating Development of SARS-CoV-2 Vaccines — the Role for Controlled Human Infection ModelsJuly 2020

Press Mentions

  • Covid Has Settled into a Persistent Pattern — and Remains Damaging. It May Not Change Anytime Soon
    Covid Has Settled into a Persistent Pattern — and Remains Damaging. It May Not Change Anytime SoonAugust 4th, 2022
  • UMD School of Medicine Professors Conducts COVID-19 Booster Research, Presents to FDA
    UMD School of Medicine Professors Conducts COVID-19 Booster Research, Presents to FDAOctober 7th, 2021
  • U.K. Government Invests $43 Million in Vaccine Trials That Deliberately Infect Volunteers with Covid-19
    U.K. Government Invests $43 Million in Vaccine Trials That Deliberately Infect Volunteers with Covid-19October 20th, 2020
  • Join now to see all

Dr. Meagan Deming, Dr. Meagan Deming, MD, Dr. M Deming